Welcome to Helix Talk, a podcast presented by the Rosalind Franklin University College of Pharmacy.

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics.

We're hoping that our real-life clinical pearls and discussions will help you stay up to date

and improve your pharmacy knowledge.

This is an educational production copyright Rosalind Franklin University of Medicine and Science.

This podcast contains general information for educational purposes only. This is not professional advice and should

not be used in lieu of obtaining advice from a qualified health care provider. And now, on to the show.

Welcome to episode 11 of Helix Talk. I'm your co-host Dr. Kane.

I'm Dr. Schumann.

And I'm Dr. Patel.

And we actually have a special guest here, and I'll let him introduce himself in some of his background.

We're really excited to have him today.

So my name is Mike Fenewald, and I'm a faculty member in the Microbiology and Immunology Department here at Rosalind Franklin.

I got a PhD at the University of Chicago in Microbiology and Immunology, and I've been on the faculty here for 25 years.

Perfect.

Welcome, Dr. Fenelow.

Welcome.

So Dr. Fennoll, we wanted to have you come in here today as part of, as you know, the mission of Rosalind Franklin is a very interprofessional environment. And we thought it would be great to have you come in. And I know that

one of the topics that you wanted to discuss today is Bordetella pertussis. What made you want to pick

that topic for today? Well, there were a number of reasons. First of all, Bordadella

pertussis causes two different clinical syndromes.

And in infinite children, the syndrome is usually called whooping cough, but in teens and adults,

...